Charles F Wagner Jr insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | VRTX | ↓ Sell | 9,532 | $461.00 | $4.4M | Direct | Jan 8, 2026 (2d) |
| Dec 3, 2025 | VRTX | ↓ Sell | 14,000 | $456.00 | $6.4M | Direct | Dec 5, 2025 (2d) |
| Mar 10, 2025 | VRTX | ↓ Sell | 3,298 | $500.00 | $1.6M | Direct | Mar 12, 2025 (2d) |
| Nov 11, 2024 | VRTX | ↓ Sell | 3,000 | $518.27 | $1.6M | Direct | Nov 13, 2024 (2d) |
| Jun 3, 2024 | VRTX | ↓ Sell | 3,250 | $460.00 | $1.5M | Direct | Jun 5, 2024 (2d) |
| May 28, 2024 | VRTX | ↓ Sell | 3,250 | $454.79 | $1.5M | Direct | May 30, 2024 (2d) |
| Jan 2, 2024 | VRTX | ↓ Sell | 3,000 | $405.00 | $1.2M | Direct | Jan 4, 2024 (2d) |
| Nov 20, 2023 | VRTX | ↓ Sell | 3,000 | $349.88 | $1.0M | Direct | Nov 21, 2023 (1d) |
| Mar 24, 2023 | VRTX | ↓ Sell | 1,768 | $305.38 | $540K | Direct | Mar 28, 2023 (4d) |
| Mar 17, 2023 | VRTX | ↓ Sell | 2,000 | $296.39 | $593K | Direct | Mar 21, 2023 (4d) |
| Mar 13, 2023 | VRTX | ↓ Sell | 4,754 | $291.98 | $1.4M | Direct | Mar 14, 2023 (1d) |
| May 2, 2022 | VRTX | ↓ Sell | 343 | $258.83 | $89K | Direct | May 4, 2022 (2d) |
| Apr 1, 2022 | VRTX | ↓ Sell | 2,582 | $264.76 | $684K | Direct | Apr 5, 2022 (4d) |
| Mar 17, 2022 | VRTX | ↓ Sell | 3,171 | $250.15 | $793K | Direct | Mar 21, 2022 (4d) |
| Feb 2, 2022 | VRTX | ↓ Sell | 2,944 | $250.07 | $736K | Direct | Feb 3, 2022 (1d) |
| Jul 10, 2020 | VRTX | ↓ Sell | 700 | $293.15 | $205K | Direct | Jul 14, 2020 (4d) |
| Mar 17, 2015 | BRKR | ↓ Sell | 19,000 | $18.97 | $360K | Direct | Mar 18, 2015 (1d) |
| May 11, 2007 | MIL | ↓ Sell | 1 | $57.18 | $43 | Direct | May 22, 2007 (11d) |
| Feb 14, 2007 | MIL | ↓ Sell | 10,000 | $74.74 | $747K | Direct | Feb 16, 2007 (2d) |
| Feb 14, 2006 | MIL | ↓ Sell | 8,250 | $66.17 | $546K | Direct | Feb 15, 2006 (1d) |
| Aug 5, 2005 | MIL | ↓ Sell | 8,250 | $60.24 | $497K | Direct | Aug 5, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Charles F Wagner Jr's insider trades
Charles F Wagner Jr is EVP, Co & Fo at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Aug 5, 2005, Charles has reported no open-market purchases and 21 sales worth $26.4M on SEC Form 4. In the last 12 months: 2 sales ($10.8M).
Their filings also include shares withheld for taxes (31 filings), grants and awards (29 filings), option exercises (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.